Loading organization details...
Loading organization details...
TO FUND RESEARCH WITH THE HIGHEST PROBABILITY OF PREVENTING, SLOWING OR REVERSING ALZHEIMER'S DISEASE.
Source: IRS Form 990 (Tax Year 2023)
Source: IRS e-Filed Form 990 (from the IRS e-File system), Tax Year 2023
Total Revenue
▼$37.7M
Program Spending
91%
of total expenses go to program services
Total Contributions
$36.7M
Total Expenses
▼$34.6M
Total Assets
$33.5M
Total Liabilities
▼$1.7M
Net Assets
$31.8M
Officer Compensation
→$1.7M
Other Salaries
$2.6M
Investment Income
$1M
Fundraising
▼$70.2K
Tax Year 2023 · Source: IRS Form 990, Schedule I (Grants and Other Assistance)
Total grants awarded: $23.1M
| Recipient | Location | Amount | Type | Purpose |
|---|---|---|---|---|
MASSACHUSETTS GENERAL HOSPITAL | BOSTON, MA | $2M | Cash | THE CUREALZ ALZHEIMER'S GENOME PROJECT |
BRIGHAM AND WOMEN'S HOSPITAL | BOSTON, MA | $431.3K | Cash | A NEW MODEL OF MICROGLIA GENETIC PERTURBATION IN VIVO TO SCREEN ALL RISK FACTORS ASSOCIATED WITH ALZHEIMER'S DISEASE |
MASSACHUSETTS GENERAL HOSPITAL | BOSTON, MA | $345K | Cash | NEUROPROTECTIVE EFFECTS OF THE EXERCISE HORMONE IRISIN IN ALZHEIMER'S DISEASE |
NORTHWESTERN UNIVERSITY36-2167817 | CHICAGO, IL | $345K | Cash | MBC: INTERACTION OF THE MICROBIOME WITH ASTROCYTES AND AMYLOID PATHOLOGY |
WASHINGTON UNIVERSITY43-0653611 | ST LOUIS, MO | $345K | Cash | BEE: CROSSTALK OF CNS BARRIERS AND CLEARANCE ROUTES IN HOMEOSTASIS AND ALZHEIMER'S DISEASE |
WASHINGTON UNIVERSITY43-0653611 | ST LOUIS, MO | $345K | Cash | APOE CONSORTIUM: ROLE OF APOE ISOFORMS IN IMMUNE RESPONSES IN A MODEL OF TAUOPATHY |
BOSTON CHILDREN'S HOSPITAL | BOSTON, MA | $344.1K | Cash | NIC: EFFECTS OF PERIPHERAL INFLAMMATION ON MYELOID CELL FUNCTION IN ALZHEIMER'S DISEASE |
UNIVERSITY OF SOUTHERN CALIFORNIA95-1642394 | LOS ANGELES, CA | $301.1K | Cash | AIR POLLUTION AND AD RISK INTERACT WITH PREMATURE AGING OF NEURAL STEM CELLS AND APOE ALLELES |
MASSACHUSETTS GENERAL HOSPITAL | BOSTON, MA | $300K | Cash | UNDERSTANDING HUMAN BRAIN RESILIENCE TO ALZHEIMER'S PATHOLOGY |
MASSACHUSETTS INSTITUTE OF TECHNOLOGY | CAMBRIDGE, MA | $300K | Cash | CIRCUITS: DISSECTING MICROGLIAL STATE DYNAMICS IN ALZHEIMER'S DISEASE |
BOSTON UNIVERSITY | BOSTON, MA | $287.5K | Cash | APOE CONSORTIUM: MODULATION OF SELECTIVE NEURONAL VULNERABILITY IN ALZHEIMER'S DISEASE BY APOE |
BRIGHAM AND WOMEN'S HOSPITAL | BOSTON, MA | $287.5K | Cash | APOE CONSORTIUM: APOE4-MEDIATED DYSFUNCTION OF CD8 T CELL-MICROGLIA CROSSTALK IN ALZHEIMER'S DISEASE |
BRIGHAM AND WOMEN'S HOSPITAL | BOSTON, MA | $287.5K | Cash | MBC: HARNESSING DIET-MICROBE INTERACTIONS TO PREVENT ALZHEIMER'S DISEASE PATHOGENESIS |
MASSACHUSETTS GENERAL HOSPITAL | BOSTON, MA | $287.5K | Cash | MBC: MICROBIAL PROFILING OF HUMAN BRAIN AND GUT MICROBIOMES IN ALZHEIMER'S DISEASE |
UNIVERSITY OF CALIFORNIA SAN DIEGO95-2872494 | LA JOLLA, CA | $287.5K | Cash | NIC: MECHANISMS MEDIATING MICROGLIA SENSING OF PERIPHERAL INFLAMMATION |
UNIVERSITY OF CALIFORNIA SAN DIEGO95-2872494 | LA JOLLA, CA | $287.5K | Cash | BEE: IDENTIFYING THE BLOOD-BRAIN BARRIER CHANGES DURING ALZHEIMER'S DISEASE |
WASHINGTON UNIVERSITY43-0653611 | ST LOUIS, MO | $287.5K | Cash | MBC: THE ROLE OF GUT MICROBIAL METABOLISM IN TAU-MEDIATED NEURODEGENERATION |
WEILL CORNELL13-6094042 | NEW YORK, NY | $287.5K | Cash | BEE: BIOCHEMICAL AND FUNCTIONAL ANALYSIS OF CSF AND LYMPH FOLLOWING CHANGES IN BRAIN FLUID DYNAMICS |
UNIVERSITY OF CALIFORNIA IRVINE95-2226406 | IRVINE, CA | $287.5K | Cash | NIC: EXAMINING THE IMPACT OF PERIPHERALLY DERIVED HUMAN MACROPHAGES IN AD PATHOGENESIS |
MASSACHUSETTS GENERAL HOSPITAL | BOSTON, MA | $287.2K | Cash | ADTC: HOW DO SOLUBLE TAU SPECIES REPLICATE? |
UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER75-2556007 | DALLAS, TX | $287K | Cash | ADTC: ROLE OF VCP/P97 IN TAU PRION REPLICATION |
NORTHWESTERN UNIVERSITY36-2167817 | CHICAGO, IL | $286.4K | Cash | ADTC: THE ROLE OF A-INDUCED MEMBRANE DAMAGE IN TAU PATHOLOGY |
MASSACHUSETTS GENERAL HOSPITAL | BOSTON, MA | $258.8K | Cash | FUNCTIONAL CHANGES TO CEREBROSPINAL FLUID IMMUNE CELLS RESULTING FROM BACILLUS CALMETTE-GURIN (BCG) VACCINATION IN OLDER ADULTS WITH AND WITHOUT ALZHEIMER'S DISEASE |
UNIVERSITY OF CHICAGO36-2177139 | CHICAGO, IL | $250K | Cash | MBC: TEMPORAL RELATIONSHIPS BETWEEN GUT DYSBIOSIS, BRAIN AB METABOLISM AND MICROGLIA CELL ACTIVATION FOLLOWING ANTIBIOTIC TREATMENT |
UNIVERSITY OF SOUTHERN CALIFORNIA95-1642394 | LOS ANGELES, CA | $250K | Cash | CELLULAR AND MOLECULAR STUDIES OF APOE REGULATION OF BLOOD-BRAIN BARRIER, SYNAPTIC AND NEURONAL FUNCTIONS AND PROTECTION STRATEGIES IN MOUSE MODELS WITH AND WITHOUT ALZHEIMER'S PAHTOLOGY |
WEILL CORNELL13-6094042 | NEW YORK, NY | $250K | Cash | DEVELOPMENT OF HUMAN CGAS INHIBITORS TO TREAT ALZHEIMER'S DISEASE |
UNIVERSITY OF SOUTHERN CALIFORNIA95-1642394 | LOS ANGELES, CA | $234.7K | Cash | PROTECTION AGAINST APOE4 WITH LONGEVITY-PROMOTING INTERVENTIONS |
MASSACHUSETTS GENERAL HOSPITAL | BOSTON, MA | $230K | Cash | BEE: A 3D IN-VITRO NEURO-VASCULAR HUMAN BRAIN MODEL WITH MENINGEAL LYMPHATICS FOR ELUCIDATING MECHANISMS UNDERLYING ALZHEIMER'S DISEASE |
MEMORIAL SLOAN KETTERING CANCER CENTER13-1924236 | NEW YORK, NY | $230K | Cash | THE ROLE OF IFITM3 AND Y-SECRETASE IN MICROGLIA |
UNIVERSITY OF CALIFORNIA IRVINE95-2226406 | IRVINE, CA | $230K | Cash | ENDOGENOUS HUMAN ANTIBODIES ASSOCIATED WITH ALZHEIMER'S DISEASE |
UNIVERSITY OF CALIFORNIA SAN DIEGO95-2872494 | LA JOLLA, CA | $230K | Cash | APP GENE DOSE-MEDIATED DYSREGULATION OF THE ENDOLYSOSOMAL NETWORK ACTS COMPROMISE SYNAPTIC STRUCTURE AND FUNCTION LEADING TO ALZHEIMER'S DISEASE IN DOWN SYNDROME |
UNIVERSITY OF CONNECTICUT | FARMINGTON, CT | $230K | Cash | AD PATHOPHYSIOLOGY ALTERS THE LEVEL OF ELECTRICAL AND CHEMICAL SYNAPSE COUPLING IN THE NETWORK OF GABAERGIC PV+ INTERNEURONS EARLY IN DISEASE COURSE |
UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER75-2556007 | DALLAS, TX | $230K | Cash | RNA AS A DETERMINANT OF TAU SEEDING |
DUKE UNIVERSITY SCHOOL OF MEDICINE56-0532129 | DURHAM, NC | $230K | Cash | UTILITY OF BLOOD BASED MARKERS FOR PREDICTING ARIA AND ITS COURSE IN MCI AND AD SUBJECTS UNDERGOING ROUTINE CLINICAL TREATMENT WITH AMYLOID-DIRECTED ANTIBODIES |
HARVARD MEDICAL SCHOOL | CAMBRIDGE, MA | $220.1K | Cash | ANALYTICAL AND STATISTICAL TOOLS FOR SEQUENCE ANALYSIS FOR ALZHEIMER'S DISEASE |
NEW YORK UNIVERSITY13-5562308 | NEW YORK, NY | $208K | Cash | MECHANISMS OF ASTROCYTE-DERIVED LIPID TOXICITY IN ALZHEIMER'S DISEASE |
YALE UNIVERSITY | NEW HAVEN, CT | $204.1K | Cash | BEE: CNS FLUID HOMEOSTASIS AND WASTE CLEARANCE IN ALZHEIMER'S DISEASE CHARACTERIZED BY MRI |
COLUMBIA UNIVERSITY13-5598093 | NEW YORK, NY | $201.5K | Cash | NEUROPROTEASOMES MECHANISTICALLY CONNECT APOE ISOFORMS TO ENDOGENOUS TAU AGGREGATION |
BRIGHAM AND WOMEN'S HOSPITAL | BOSTON, MA | $201.3K | Cash | TARGETING NEUROINFLAMMATION WITH NASAL ADMINISTRATION OF ANTI-CD3 MONOCLONAL ANTIBODY TO TREAT ALZHEIMER'S DISEASE |
BRIGHAM AND WOMEN'S HOSPITAL | BOSTON, MA | $201.3K | Cash | ROLE OF CHECKPOINT MOLECULES TIM-3 AND LAG-3 IN MICROGLIAL FUNCTION IN ALZHEIMER'S DISEASE |
BRIGHAM AND WOMEN'S HOSPITAL | BOSTON, MA | $201.3K | Cash | NEUROIMMUNE CONNECTOME PERTURBATIONS IN ALZHEIMER'S DISEASE |
BRIGHAM AND WOMEN'S HOSPITAL | BOSTON, MA | $201.3K | Cash | TARGETING THE MICROBIOME AND INNATE IMMUNITY IN ALZHEIMER'S DISEASE |
COLUMBIA UNIVERSITY13-5598093 | NEW YORK, NY | $201.3K | Cash | NONCODING TRANSLATION FEEDBACK LOOP IN ALZHEIMER'S DISEASE |
EMORY UNIVERSITY58-0566256 | ATLANTA, GA | $201.3K | Cash | MITOCHONDRIAL ALZHEIMER'S RISK FACTORS CONTROL APOE EXPRESSION AND SECRETION |
ICAHN SCOOL OF MEDICINE AT MOUNT SINAI13-6171197 | NEW YORK, NY | $201.3K | Cash | INVESTIGATING MEF2C TRANSCRIPTION FACTOR AS THERAPEUTIC TARGET TO REPROGRAM PATHOLOGICAL MICROGLIAL STATES IN ALZHEIMER'S DISEASE |
ICAHN SCOOL OF MEDICINE AT MOUNT SINAI13-6171197 | NEW YORK, NY | $201.3K | Cash | INVESTIGATING LYSOSOMAL MECHANISMS OF RISK AND RESILIENCE IN ALZHEIMER'S DISEASE |
JOHNS HOPKINS UNIVERSITY52-0595110 | BALTIMORE, MD | $201.3K | Cash | HUMAN BRAIN CD33 LIGAND, RPTPS3L, LIMITS MICROGLIAL PHAGOCYTOSIS AND CONTRIBUTES TO ALZHEIMER'S DISEASE PROGRESSION |
MASSACHUSETTS GENERAL HOSPITAL | BOSTON, MA | $201.3K | Cash | ROLE OF STABILIZATION OF MAMS AND MAM-ASSOCIATED PALMITOYLATED APP (MAM-PALAPP) IN ALZHEIMER'S DISEASE |
MASSACHUSETTS GENERAL HOSPITAL | BOSTON, MA | $201.3K | Cash | ROLE OF RIN3 AND BIN1 INTERACTION IN THE NEURONS FOR ALZHEIMER'S DISEASE DEVELOPMENT |
MASSACHUSETTS GENERAL HOSPITAL | BOSTON, MA | $201.3K | Cash | CHARACTERIZING GUT BACTERIOME-MYCOBIOME SYNERGY IN CORRELATION TO AMYLIN-A ANTIMICROBIAL SYNERGY IN ALZHEIMER'S DISEASE (AD) IN AD MOUSE MODELS |
MASSACHUSETTS GENERAL HOSPITAL | BOSTON, MA | $201.3K | Cash | ROLE OF CD8+ T CELL-GLIAL INTERACTIONS IN MEDIATING ALZHEIMER'S DISEASE PATHOGENESIS |
MASSACHUSETTS GENERAL HOSPITAL | BOSTON, MA | $201.3K | Cash | VALIDATION AND CHARACTERIZATION OF COMPOUNDS MODULATING NEUROINFLAMMATION AND AMYLOID BETA UPTAKE IN MICROGLIAL CELLS |
MASSACHUSETTS GENERAL HOSPITAL | BOSTON, MA | $201.3K | Cash | CHARACTERIZATION OF CNS-PENETRANT HDAC11-SELECTIVE INHIBITORS IN ALZHEIMER'S DISEASE MODELS |
MASSACHUSETTS GENERAL HOSPITAL | BOSTON, MA | $201.3K | Cash | GROWTH, CHARACTERIZATION, AND DISTRIBUTION OF A NEURODEGENERATIVE DISEASE-FOCUSED FIBROBLAST/IPS CELL BANK TO SUPPORT MOLECULAR MODELS OF PATIENT-SPECIFIC VARIATION WITH VALIDATION IN MATCHED DONATED BRAIN TISSUES |
MAYO CLINIC JACKSONVILLE59-3337028 | JACKSONVILLE, FL | $201.3K | Cash | RESTORE MENINGEAL LYMPHATIC DRAINAGE TO ALLEVIATE WHITE MATTER DAMAGE AND CEREBRAL AMYLOID ANGIOPATHY IN A MODEL OF ALZHEIMER'S DISEASE |
MAYO CLINIC JACKSONVILLE59-3337028 | JACKSONVILLE, FL | $201.3K | Cash | ABCA7 LOSS OF FUNCTION IN AGING AND ALZHEIMER'S DISEASE |
MAYO CLINIC JACKSONVILLE59-3337028 | JACKSONVILLE, FL | $201.3K | Cash | EVALUATING TMEM106B ACCUMULATION IN AD |
MAYO CLINIC JACKSONVILLE59-3337028 | JACKSONVILLE, FL | $201.3K | Cash | ELUCIDATING THE PROTECTIVE EFFECTS OF APOE2 IN THE PRESENCE OF APOE4 GENE ALLELE IN ANIMAL MODELS |
STANFORD UNIVERSITY94-1156365 | REDWOOD CITY, CA | $201.3K | Cash | MULTIOMICS CHARACTERIZATION OF TAU PATHOLOGY ONSET AND ITS RELATIONSHIP WITH AMYLOID IN THE HUMAN HIPPOCAMPUS |
THE REGENTS OF THE UNIVERSITY OF CALIFORMIA SAN FRANCISCO94-3067788 | SAN FRANCISCO, CA | $201.3K | Cash | NEURONAL MECHANISMS DRIVING SYNAPSE LOSS IN ALZHEIMER'S DISEASE |
THE SALK INSTITUTE FOR BIOLOGIAL STUDIES95-2160097 | LA JOLLA, CA | $201.3K | Cash | TO ELUCIDATE THE ROLE OF MEMORY T CELLS AS A DETERMINANT OF AGE-RELATED INFLAMMATION IN ALZHEIMER'S DISEASE |
TUFTS UNIVERSITY | BOSTON, MA | $201.3K | Cash | MULTIDISCIPLINARY PHENOTYPING OF A NOVEL HUMANIZED LOAD MOUSE MODEL |
UNIVERSITY OF MICHIGAN38-6006309 | ANN ARBOR, MI | $201.3K | Cash | MORPHOLOGICAL, ELECTROPHYSIOLOGICAL, AND TRANSCRIPTIONAL CHARACTERIZATION OF SINGLE NEURONS FROM RESILIENT AND SUSCEPTIBLE MODELS OF HUMAN AD |
UNIVERSITY OF RHODE ISLAND22-3011455 | KINGSTON, RI | $201.3K | Cash | EFFECT OF APOE GENOTYPE IN A NOVEL RAT MODEL OF CEREBRAL AMYLOID ANGIOPATHY |
UNIVERSITY OF SOUTHERN CALIFORNIA95-1642394 | LOS ANGELES, CA | $201.3K | Cash | PRENATAL INFLAMMATION EFFECTS ON BLOOD BRAIN BARRIER FUNCTION AND AD-RELATED PATHOLOGIES ACROSS THE LIFESPAN |
UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO74-1586031 | SAN ANTONIO, TX | $201.3K | Cash | IDENTIFICATION AND VALIDATION OF PLASMA-BASED LIPID BIOMARKERS FOR EARLY ALZHEIMER'S DISEASE IN THE UNIQUE, PRIMARILY HISPANIC, SOUTH TEXAS POPULATION |
UNIVERSITY OF VIRGINIA54-6001796 | CHARLOTTESVILLE, VA | $201.3K | Cash | ELUCIDATING THE ROLE OF CLEC7A IN TAU-MEDIATED NEURODEGENERATIVE DISEASE |
UNIVERSITY OF VIRGINIA54-6001796 | CHARLOTTESVILLE, VA | $201.3K | Cash | EXPLORING THE THERAPEUTIC POTENTIAL OF CLUSTERIN IN A PRECLINICAL MODEL OF ALZHEIMER'S DISEASE |
WASHINGTON UNIVERSITY43-0653611 | ST LOUIS, MO | $201.3K | Cash | CONTRIBUTION OF SKULL BONE MARROW-DERIVED CELLS TO ALZHEIMER'S DISEASE |
WASHINGTON UNIVERSITY43-0653611 | ST LOUIS, MO | $201.3K | Cash | DISSECTING ALZHEIMER'S DISEASE PHENOTYPES IN DIRECTLY REPROGRAMMED PATIENT-DERIVED NEURONS |
WEILL CORNELL13-6094042 | NEW YORK, NY | $201.3K | Cash | IDENTIFICATION AND DEVELOPMENT OF CD33 INHIBITORS AND PRE-RNA SPLICING MODULATORS |
WEILL CORNELL13-6094042 | NEW YORK, NY | $201.3K | Cash | TAU-INDUCED POSTSYNAPTIC DYSFUNCTION IN TAUOPATHY MODELS |
WASHINGTON UNIVERSITY43-0653611 | ST LOUIS, MO | $201.2K | Cash | ANTIVIRAL T CELLS INFILTRATION TO THE MENINGES AND BRAIN INFLUENCES NEURODEGENERATION IN ALZHEIMER'S DISEASE |
THE METHODIST HOSPITAL FOUNDATION76-0094743 | HOUSTON, TX | $201.2K | Cash | A MUTI-MODALITY STUDY ON LIPID MOLECULAR BASIS OF OBESITY AND ITS ROLES IN REGULATING ALZHEIMER'S PATHOGENESIS FOR DEVELOPING POTENTIAL TARGETED INTERVENTIONS |
WASHINGTON UNIVERSITY43-0653611 | ST LOUIS, MO | $199K | Cash | CIRCADIAN DESYNCHRONY, GLIAL DYSFUNCTION, AND ALZHEIMER'S DISEASE PATHOGENESIS |
STANFORD UNIVERSITY94-1156365 | REDWOOD CITY, CA | $198.8K | Cash | OLIGODENDROGLIAL DYNAMICS AND MYELINATION IN ALZHEIMER'S DISEASE |
DUKE UNIVERSITY SCHOOL OF MEDICINE56-0532129 | DURHAM, NC | $195.4K | Cash | CONTRIBUTIONS OF IL34 SIGNALING TO MICROGLIAL FUNCTION AND ALZHEIMER'S PATHOLOGY IN MICE |
UNIVERSITY OF VIRGINIA54-6001796 | CHARLOTTESVILLE, VA | $192K | Cash | TOXIC EFFECTS OF EXTRACELLULAR TAU OLIGOMERS ON NEURONS |
WASHINGTON UNIVERSITY43-0653611 | ST LOUIS, MO | $189.9K | Cash | DECIPHERING AND RESTORING COMPUTATIONAL SET-POINTS IN ALZHEIMER'S DISEASE THROUGH SLEEP-ENHANCED NETWORK HOMEOSTASIS |
BOSTON CHILDREN'S HOSPITAL | BOSTON, MA | $189.8K | Cash | NEUROINFLAMMATION AT THE CHOROID PLEXUS IN ALZHEIMER'S DISEASE |
BROAD INSTITUTE26-3428781 | CAMBRIDGE, MA | $172.6K | Cash | REVEALING NEW GENES AND PATHWAYS AT THE INTERSECTION OF LIPOTOXIC AND GENETIC RISK FOR ALZHEIMER'S DISEASE |
ICAHN SCOOL OF MEDICINE AT MOUNT SINAI13-6171197 | NEW YORK, NY | $172.5K | Cash | IN VIVO MODELS FOR GOLGI FRAGMENTATION AND THE MOLECULAR PATHOGENESIS OF ALZHEIMER'S DISEASE |
ICAHN SCOOL OF MEDICINE AT MOUNT SINAI13-6171197 | NEW YORK, NY | $172.5K | Cash | STRESS AND NEUROVASCULAR-IMMUNE NETWORKS IN ALZHEIMER'S DISEASE |
ICAHN SCOOL OF MEDICINE AT MOUNT SINAI13-6171197 | NEW YORK, NY | $172.5K | Cash | INVESTIGATING BONE MARROW HEMATOPOIESIS AND THE LINK BETWEEN SLEEP FRAGMENTATION AND VASCULAR INFLAMMATION IN AD |
MASSACHUSETTS GENERAL HOSPITAL | BOSTON, MA | $172.5K | Cash | TAU AND -AMYLOID ARE INNATE IMMUNE ANTIMICROBIAL PEPTIDES IN THE BRAIN |
MAYO CLINIC JACKSONVILLE59-3337028 | JACKSONVILLE, FL | $172.5K | Cash | TARGETING MICROGLIAL TSG 101 FOR SYNAPTIC PROTECTION AND COGNITIVE ENHANCEMENT IN ALZHEIMER'S DISEASE |
NORTHWESTERN UNIVERSITY36-2167817 | CHICAGO, IL | $172.5K | Cash | T CELL EPIGENETICS IN ALZHEIMER'S DISEASE |
THE SALK INSTITUTE FOR BIOLOGIAL STUDIES95-2160097 | LA JOLLA, CA | $172.5K | Cash | THE ROLE OF ASTROCYTE-SECRETED IGFBP2 IN THE PROGRESSION OF ALZHEIMER'S DISEASE |
WASHINGTON UNIVERSITY43-0653611 | ST LOUIS, MO | $172.5K | Cash | UNDERSTANDING THE ROLE OF NATURAL A-SPECIFIC B CELL RESPONSES IN AD PROGRESSION |
MASSACHUSETTS GENERAL HOSPITAL | BOSTON, MA | $172K | Cash | REGIONAL VARIABILITY OF PATHOLOGY-ASSOCIATED PROPERTIES OF TAU IN POSTERIOR CORTICAL ATROPHY |
HARVARD MEDICAL SCHOOL | CAMBRIDGE, MA | $150K | Cash | PRECISION MEDICINE PREDICTION MODEL FOR ALZHEIMER'S DISEASE USING COOPERATIVE LEARNING APPROACHES FOR MULTI-OMIC DATA |
NORTHWESTERN UNIVERSITY36-2167817 | CHICAGO, IL | $136.8K | Cash | INTERROGATING LEVETIRACETAM'S IMPACT ON AMYLOID PATHOLOGY AND PRESYNAPTIC PROTEOSTASIS IN KNOCK-IN MOUSE MODELS WITH HUMANIZED ABETA |
MASSACHUSETTS GENERAL HOSPITAL | BOSTON, MA | $125K | Cash | THE IMPACT OF MUTATIONS IN THE LIGAND-BINDING DOMAIN OF CD33 ON ALZHEIMER'S DISEASE PATHOGENESIS |
BETH ISRAEL DEACONESS MEDICAL CENTER | BOSTON, MA | $118.5K | Cash | AGP: GENOMIC VARIANT CALLING AND DATA MANAGEMENT FOR THE CURE ALZHEIMER'S FUND ALZHEIMER'S GENOME PROJECT |
WASHINGTON UNIVERSITY43-0653611 | ST LOUIS, MO | $113.7K | Cash | CHARACTERIZATION OF MOLECULAR BIOMARKER PROFILES THROUGHOUT THE PATHOBIOLOGICAL CONTINUUM |
MASSACHUSETTS GENERAL HOSPITAL | BOSTON, MA | $95.6K | Cash | GENERAL SCIENTIFIC SUPPORT |
UNIVERSITY OF MICHIGAN38-6006309 | ANN ARBOR, MI | $57.5K | Cash | IN VIVO MODELS FOR GOLGI FRAGMENTATION AND THE MOLECULAR PATHOGENESIS OF ALZHEIMER'S DISEASE |
HARVARD MEDICAL SCHOOL | BOSTON, MA | $40.3K | Cash | GENETIC ANCESTRY-SPECIFIC RISK ESTIMATION OF ALZHEIMER'S DISEASE (AD) IN THE APOE REGION |
| Total | $23.1M | |||
MASSACHUSETTS GENERAL HOSPITAL
BOSTON, MA
$2M
BRIGHAM AND WOMEN'S HOSPITAL
BOSTON, MA
$431.3K
MASSACHUSETTS GENERAL HOSPITAL
BOSTON, MA
$345K
CHICAGO, IL
$345K
ST LOUIS, MO
$345K
ST LOUIS, MO
$345K
BOSTON CHILDREN'S HOSPITAL
BOSTON, MA
$344.1K
UNIVERSITY OF SOUTHERN CALIFORNIA
LOS ANGELES, CA
$301.1K
MASSACHUSETTS GENERAL HOSPITAL
BOSTON, MA
$300K
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
CAMBRIDGE, MA
$300K
BOSTON UNIVERSITY
BOSTON, MA
$287.5K
BRIGHAM AND WOMEN'S HOSPITAL
BOSTON, MA
$287.5K
BRIGHAM AND WOMEN'S HOSPITAL
BOSTON, MA
$287.5K
MASSACHUSETTS GENERAL HOSPITAL
BOSTON, MA
$287.5K
UNIVERSITY OF CALIFORNIA SAN DIEGO
LA JOLLA, CA
$287.5K
UNIVERSITY OF CALIFORNIA SAN DIEGO
LA JOLLA, CA
$287.5K
ST LOUIS, MO
$287.5K
NEW YORK, NY
$287.5K
UNIVERSITY OF CALIFORNIA IRVINE
IRVINE, CA
$287.5K
MASSACHUSETTS GENERAL HOSPITAL
BOSTON, MA
$287.2K
UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER
DALLAS, TX
$287K
CHICAGO, IL
$286.4K
MASSACHUSETTS GENERAL HOSPITAL
BOSTON, MA
$258.8K
CHICAGO, IL
$250K
UNIVERSITY OF SOUTHERN CALIFORNIA
LOS ANGELES, CA
$250K
NEW YORK, NY
$250K
UNIVERSITY OF SOUTHERN CALIFORNIA
LOS ANGELES, CA
$234.7K
MASSACHUSETTS GENERAL HOSPITAL
BOSTON, MA
$230K
NEW YORK, NY
$230K
UNIVERSITY OF CALIFORNIA IRVINE
IRVINE, CA
$230K
UNIVERSITY OF CALIFORNIA SAN DIEGO
LA JOLLA, CA
$230K
UNIVERSITY OF CONNECTICUT
FARMINGTON, CT
$230K
UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER
DALLAS, TX
$230K
DURHAM, NC
$230K
HARVARD MEDICAL SCHOOL
CAMBRIDGE, MA
$220.1K
NEW YORK, NY
$208K
YALE UNIVERSITY
NEW HAVEN, CT
$204.1K
NEW YORK, NY
$201.5K
BRIGHAM AND WOMEN'S HOSPITAL
BOSTON, MA
$201.3K
BRIGHAM AND WOMEN'S HOSPITAL
BOSTON, MA
$201.3K
BRIGHAM AND WOMEN'S HOSPITAL
BOSTON, MA
$201.3K
BRIGHAM AND WOMEN'S HOSPITAL
BOSTON, MA
$201.3K
NEW YORK, NY
$201.3K
ATLANTA, GA
$201.3K
NEW YORK, NY
$201.3K
NEW YORK, NY
$201.3K
BALTIMORE, MD
$201.3K
MASSACHUSETTS GENERAL HOSPITAL
BOSTON, MA
$201.3K
MASSACHUSETTS GENERAL HOSPITAL
BOSTON, MA
$201.3K
MASSACHUSETTS GENERAL HOSPITAL
BOSTON, MA
$201.3K
MASSACHUSETTS GENERAL HOSPITAL
BOSTON, MA
$201.3K
MASSACHUSETTS GENERAL HOSPITAL
BOSTON, MA
$201.3K
MASSACHUSETTS GENERAL HOSPITAL
BOSTON, MA
$201.3K
MASSACHUSETTS GENERAL HOSPITAL
BOSTON, MA
$201.3K
JACKSONVILLE, FL
$201.3K
JACKSONVILLE, FL
$201.3K
JACKSONVILLE, FL
$201.3K
JACKSONVILLE, FL
$201.3K
STANFORD UNIVERSITY
REDWOOD CITY, CA
$201.3K
THE REGENTS OF THE UNIVERSITY OF CALIFORMIA SAN FRANCISCO
SAN FRANCISCO, CA
$201.3K
THE SALK INSTITUTE FOR BIOLOGIAL STUDIES
LA JOLLA, CA
$201.3K
TUFTS UNIVERSITY
BOSTON, MA
$201.3K
ANN ARBOR, MI
$201.3K
UNIVERSITY OF RHODE ISLAND
KINGSTON, RI
$201.3K
UNIVERSITY OF SOUTHERN CALIFORNIA
LOS ANGELES, CA
$201.3K
UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO
SAN ANTONIO, TX
$201.3K
CHARLOTTESVILLE, VA
$201.3K
CHARLOTTESVILLE, VA
$201.3K
ST LOUIS, MO
$201.3K
ST LOUIS, MO
$201.3K
NEW YORK, NY
$201.3K
NEW YORK, NY
$201.3K
ST LOUIS, MO
$201.2K
THE METHODIST HOSPITAL FOUNDATION
HOUSTON, TX
$201.2K
ST LOUIS, MO
$199K
STANFORD UNIVERSITY
REDWOOD CITY, CA
$198.8K
DURHAM, NC
$195.4K
CHARLOTTESVILLE, VA
$192K
ST LOUIS, MO
$189.9K
BOSTON CHILDREN'S HOSPITAL
BOSTON, MA
$189.8K
CAMBRIDGE, MA
$172.6K
NEW YORK, NY
$172.5K
NEW YORK, NY
$172.5K
NEW YORK, NY
$172.5K
MASSACHUSETTS GENERAL HOSPITAL
BOSTON, MA
$172.5K
JACKSONVILLE, FL
$172.5K
CHICAGO, IL
$172.5K
THE SALK INSTITUTE FOR BIOLOGIAL STUDIES
LA JOLLA, CA
$172.5K
ST LOUIS, MO
$172.5K
MASSACHUSETTS GENERAL HOSPITAL
BOSTON, MA
$172K
HARVARD MEDICAL SCHOOL
CAMBRIDGE, MA
$150K
CHICAGO, IL
$136.8K
MASSACHUSETTS GENERAL HOSPITAL
BOSTON, MA
$125K
BETH ISRAEL DEACONESS MEDICAL CENTER
BOSTON, MA
$118.5K
ST LOUIS, MO
$113.7K
MASSACHUSETTS GENERAL HOSPITAL
BOSTON, MA
$95.6K
ANN ARBOR, MI
$57.5K
HARVARD MEDICAL SCHOOL
BOSTON, MA
$40.3K
Source: USAspending.gov
No federal awards found for this organization.
USAspending.gov tracks federal grants, cooperative agreements, and other financial assistance. Not all nonprofits receive federal funding.
Source: Federal Audit Clearinghouse (fac.gov)
No federal single audit records found for this organization.
Single audits are required for entities expending $750,000+ in federal awards annually.
Tax Year 2023 · Source: IRS e-Filed Form 990Schedule J available
Individuals serving as officers, directors, or trustees of the organization.
| Name | Title | Hrs/Wk | Compensation | Related Orgs | Other |
|---|
Source: IRS Publication 78, Auto-Revocation List & e-Postcard Data
Tax-deductible contributions: Yes
Deductibility code: PC
Sources: IRS e-Filed Form 990 (XML) & ProPublica Nonprofit Explorer
Scroll →
| Year | Revenue | Contributions | Expenses | Assets | Net Assets |
|---|---|---|---|---|---|
| 2023IRS e-File | $37.7M | $36.7M | $34.6M | $33.5M | $31.8M |
| 2022 | $40.7M | $32.4M | $30.6M | $30.2M | $28.5M |
| 2021 | $26.6M | $26.5M | $23.2M | $24M | $18.2M |
| 2020 | $22.9M | $22.9M | $21M |
Sources: ProPublica Nonprofit Explorer & IRS e-File Index
Financial data: IRS e-Filed Form 990 (Tax Year 2023)
Leadership & compensation: IRS e-Filed Form 990, Part VII (Tax Year 2023)
Organization info: IRS Business Master File
Tax-deductibility: IRS Publication 78
| Total |
|---|
| Timothy Armour | Former President & CEO (to 09/23) | 40 | $350.9K | $0 | $10.9K | $361.7K |
| Margaret Smith | CEO (as Of 10/23) | 40 | $321.5K | $0 | $28.5K | $350K |
| Josephine Antonellis | Chief Financial Officer (as Of 8/23) | 30 | $151K | $0 | $5,543 | $156.5K |
| Laurel Lyle | Secretary & VP Board Relat | 30 | $113.6K | $0 | $3,982 | $117.6K |
| Henry Mccance | Chair | 5 | $0 | $0 | $0 | $0 |
| Phyllis Rappaport | Treasurer | 2 | $0 | $0 | $0 | $0 |
Timothy Armour
Former President & CEO (to 09/23)
$361.7K
Hrs/Wk
40
Compensation
$350.9K
Related Orgs
$0
Other
$10.9K
Margaret Smith
CEO (as Of 10/23)
$350K
Hrs/Wk
40
Compensation
$321.5K
Related Orgs
$0
Other
$28.5K
Josephine Antonellis
Chief Financial Officer (as Of 8/23)
$156.5K
Hrs/Wk
30
Compensation
$151K
Related Orgs
$0
Other
$5,543
Laurel Lyle
Secretary & VP Board Relat
$117.6K
Hrs/Wk
30
Compensation
$113.6K
Related Orgs
$0
Other
$3,982
Henry Mccance
Chair
$0
Hrs/Wk
5
Compensation
$0
Related Orgs
$0
Other
$0
Phyllis Rappaport
Treasurer
$0
Hrs/Wk
2
Compensation
$0
Related Orgs
$0
Other
$0
Highest compensated employees who are not officers or directors.
| Name | Title | Hrs/Wk | Compensation | Related Orgs | Other | Total |
|---|---|---|---|---|---|---|
| Katharine Herman | EVP Development | 40 | $405.7K | $0 | $30.3K | $436K |
| Barbara Chambers | EVP Marketing & Comm. | 40 | $254.9K | $0 | $22.7K | $277.6K |
| Lisa Rand | VP Marketing & Comm. | 40 | $193.8K | $0 |
Katharine Herman
EVP Development
$436K
Hrs/Wk
40
Compensation
$405.7K
Related Orgs
$0
Other
$30.3K
Barbara Chambers
EVP Marketing & Comm.
$277.6K
Hrs/Wk
40
Compensation
$254.9K
Related Orgs
$0
Other
$22.7K
Lisa Rand
VP Marketing & Comm.
$212.1K
Hrs/Wk
40
Compensation
$193.8K
Related Orgs
$0
Other
$18.3K
Members of the governing board. Board members often serve without compensation.
| Name | Title | Hrs/Wk | Compensation | Related Orgs | Other | Total |
|---|---|---|---|---|---|---|
| Jacqueline Morby | Director | 5 | $0 | $0 | $0 | $0 |
| Jeffrey Morby | Director (deceased 9/23) | 20 | $0 | $0 | $0 | $0 |
| Richard Birnbaum | Director (as Of 7/23) | 5 | $0 | $0 | $0 | $0 |
| Robert Greenhill | Director | 5 | $0 | $0 | $0 | $0 |
Jacqueline Morby
Director
$0
Hrs/Wk
5
Compensation
$0
Related Orgs
$0
Other
$0
Jeffrey Morby
Director (deceased 9/23)
$0
Hrs/Wk
20
Compensation
$0
Related Orgs
$0
Other
$0
Richard Birnbaum
Director (as Of 7/23)
$0
Hrs/Wk
5
Compensation
$0
Related Orgs
$0
Other
$0
| $16.4M |
| $14.8M |
| 2019 | $30.6M | $30.5M | $24.3M | $13.5M | $12.9M |
| 2018 | $19.9M | $19.8M | $23.6M | $7.6M | $6.7M |
| 2017 | $17.5M | $17.5M | $19M | $10.9M | $10.4M |
| 2016 | $16.2M | $16.2M | $16.5M | $12.5M | $11.9M |
| 2015 | $11.2M | $11.2M | $13M | $12.4M | $12.3M |
| 2014 | $12.7M | $12.6M | $7.3M | $14.3M | $14.1M |
| 2013 | $6.4M | $6.4M | $6.4M | $8.9M | $8.7M |
| 2012 | $9.1M | $9.1M | $5M | $8.9M | $8.7M |
| 2011 | $4.7M | $4.7M | $3.1M | $4.6M | $4.6M |
| 2021 | 990 | Data |
| 2020 | 990 | Data |
| 2019 | 990 | Data |
| 2018 | 990 | Data |
| 2017 | 990 | Data |
| 2016 | 990 | Data |
| 2015 | 990 | Data |
| 2014 | 990 | Data |
| 2013 | 990 | Data |
| 2012 | 990 | Data |
| 2011 | 990 | Data |
| 2010 | 990 | — |
| 2009 | 990 | — |
| 2008 | 990 | — |
| 2007 | 990 | — |
| 2006 | 990 | — |
| 2005 | 990 | — |
| 2004 | 990 | — |
| $18.3K |
| $212.1K |
| John Slattery | SVP Major Gifts | 40 | $190.7K | $0 | $6,713 | $197.4K |
| Mahua Dasgupta | Sr. Philantropic Advisor | 40 | $168.9K | $0 | $25.2K | $194.1K |
| Daniel Harper | Senior Philanthropic Advisor | 40 | $181.4K | $0 | $12K | $193.3K |
| Kelly Westerhouse | VP Leadership Giving | 40 | $155.4K | $0 | $10.4K | $165.8K |
John Slattery
SVP Major Gifts
$197.4K
Hrs/Wk
40
Compensation
$190.7K
Related Orgs
$0
Other
$6,713
Mahua Dasgupta
Sr. Philantropic Advisor
$194.1K
Hrs/Wk
40
Compensation
$168.9K
Related Orgs
$0
Other
$25.2K
Daniel Harper
Senior Philanthropic Advisor
$193.3K
Hrs/Wk
40
Compensation
$181.4K
Related Orgs
$0
Other
$12K
Kelly Westerhouse
VP Leadership Giving
$165.8K
Hrs/Wk
40
Compensation
$155.4K
Related Orgs
$0
Other
$10.4K
Robert Greenhill
Director
$0
Hrs/Wk
5
Compensation
$0
Related Orgs
$0
Other
$0